flavins - CISMeF

Preferred Label : flavins;

MeSH definition : Derivatives of the dimethylisoalloxazine (7,8-dimethylbenzo[g]pteridine-2,4(3H,10H)-dione) skeleton. Flavin derivatives serve an electron transfer function as ENZYME COFACTORS in FLAVOPROTEINS.;

Wikipedia automatic translation : Flavin group;

MeSH annotation : do not confuse with FLAVONES;

Wikipedia link : https://en.wikipedia.org/wiki/Flavin group;

Is substance : O;

Details

Origin ID

D005415;

UMLS CUI

C0016213;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Clioquinol [ICD-11 Extension code]
- flavins [IUPAC Term]
Record concept(s)
- flavins [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1,5-dihydro-3-(3-sulfopropyl)lumiflavin [MeSH Supplementary Concept]
- 1,5-dihydro-N(3)-carboxymethyllumiflavin [MeSH Supplementary Concept]
- 1,5-dihydrolumiflavin [MeSH Supplementary Concept]
- 10-(2',6'-dimethylphenyl)-3-methylisoalloxazine-6,8- disulfonate [MeSH Supplementary Concept]
- 10-(carboxyethyl)flavin [MeSH Supplementary Concept]
- 10-formylmethylflavin [MeSH Supplementary Concept]
- 2,3,4,10-tetrahydro-7,10-dimethyl-2,4-dioxobenzo(g)pteridine [MeSH Supplementary Concept]
- 2-deoxo-2-phenylflavin-5-oxide [MeSH Supplementary Concept]
- 3'-boron-dipyrromethene-flavin [MeSH Supplementary Concept]
- 3,10-dimethyl-5-deazaisoalloxazine [MeSH Supplementary Concept]
- 3,7,8,9,10-pentamethylisoalloxazine [MeSH Supplementary Concept]
- 3-N-carboxymethyllumiflavin [MeSH Supplementary Concept]
- 3-benzyllumiflavin [MeSH Supplementary Concept]
- 3-methyllumiflavin [MeSH Supplementary Concept]
- 4 alpha-hydroperoxy-5-ethyl-3,8,10-trimethylisoalloxazine [MeSH Supplementary Concept]
- 4'-boron-dipyrromethene-flavin [MeSH Supplementary Concept]
- 4a,5-epoxyethano-3-methyl-4a,5-dihydrolumiflavin [MeSH Supplementary Concept]
- 5-deazaflavin [MeSH Supplementary Concept]
- 5-deazaflavin 4,5-epoxide [MeSH Supplementary Concept]
- 5-deazalumiflavin [MeSH Supplementary Concept]
- 5-thia-5-deazaflavin [MeSH Supplementary Concept]
- 7,8-dimethyl-10-(3-chlorobenzyl)isoalloxazine [MeSH Supplementary Concept]
- 7,8-dimethyl-10-(O-methylacetoxy)isoalloxasin [MeSH Supplementary Concept]
- 7,8-dimethylalloxazine [MeSH Supplementary Concept]
- 7,8-dimethylisoalloxazine-10-acetic acid-adenin-9-ylethylamine complex [MeSH Supplementary Concept]
- 7,8-dimethylisoalloxazino-10-acetic acid-tyramine (1-1) tetrahydrate complex [MeSH Supplementary Concept]
- 7-carboxylumichrome [MeSH Supplementary Concept]
- 7-hydroxy-10-methyl-5-deazaisoalloxazine [MeSH Supplementary Concept]
- 7-methyl-8-dimethylaminoisoalloxazine [MeSH Supplementary Concept]
- 8-carboxylumichrome [MeSH Supplementary Concept]
- 8-cyano-10-methyl-5-deazaisoalloxazine [MeSH Supplementary Concept]
- 8-hydroxy-10-methyl-5-deazaisoalloxazine [MeSH Supplementary Concept]
- 8-hydroxy-5-deazaisoalloxazine [MeSH Supplementary Concept]
- 8-mercaptoflavins [MeSH Supplementary Concept]
- C4a-hydroperoxyflavin [MeSH Supplementary Concept]
- N(5)-ethyl flavinium [MeSH Supplementary Concept]
- N(5)-ethyl-4a-hydroxy-3-methyl-4a,5-dihydrolumiflavin [MeSH Supplementary Concept]
- ankaflavin [MeSH Supplementary Concept]
- araboflavin [MeSH Supplementary Concept]
- blue flavin [MeSH Supplementary Concept]
- carboxymethylflavin [MeSH Supplementary Concept]
- coenzyme F 390 A [MeSH Supplementary Concept]
- coenzyme F 390 G [MeSH Supplementary Concept]
- high fluorescent intermediate II [MeSH Supplementary Concept]
- hydroxymethylflavin [MeSH Supplementary Concept]
- isoalloxazine [MeSH Supplementary Concept]
- lumichrome hydrolyzate [MeSH Supplementary Concept]
- lumiflavin [MeSH Supplementary Concept]
- lyxoflavin 5'-monophosphate [MeSH Supplementary Concept]
- methyl-ethyl-monohydro-lumiflavin [MeSH Supplementary Concept]
- methylformylisoalloxazine [MeSH Supplementary Concept]
- nicoflavin [MeSH Supplementary Concept]
- ribofuranosyllumichrome [MeSH Supplementary Concept]
- schizoflavins [MeSH Supplementary Concept]
- sorboflavin [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients